MedTrace Logo

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

NCT05352204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2023-02-14

No results posted yet for this study

Summary

Micronecrosis is a novel pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the effect of tumor micronecrosis on postoperative transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinomas, and further exploring the value of micronecrosis for guiding TACE in HCC management.

Conditions

  • Carcinoma, Hepatocellular

Interventions

PROCEDURE

transcatheter arterial chemoembolization

transcatheter arterial chemoembolization after liver resection

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2022-01-01
Completion
2022-04-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352204 on ClinicalTrials.gov